Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 213.97 |
| Open | 214.87 |
| Bid | 218.78 x 1200 |
| Ask | 260.00 x 800 |
| Day's range | 213.82 - 219.32 |
| 52-week range | 203.37 - 460.21 |
| Volume | |
| Avg. volume | 556,849 |
| Market cap | 11.118B |
| Beta (5Y monthly) | 1.27 |
| PE ratio (TTM) | 26.67 |
| EPS (TTM) | 8.20 |
| Earnings date | 02 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 327.64 |
- Zacks
Charles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal
Charles River's (CRL) industry knowledge in plasmid DNA production will benefit Ziphius Vaccines' early-stage saRNA manufacturing program.
- Simply Wall St.
Could The Market Be Wrong About Charles River Laboratories International, Inc. (NYSE:CRL) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Charles River Laboratories International's (NYSE:CRL) recent performance...
- Business Wire
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
WILMINGTON, Mass. & MACCLESFIELD, England, June 28, 2022--Charles River announces the opening of their High Quality Plasmid DNA Centre of Excellence at Bruntwood SciTech’s Alderley Park.
© 2022 Yahoo. All rights reserved.
